CLOV(CLOV)
CLOV
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $2.91B | $3.32B | $3.67B | $4.31B | $4.80B |
| Low | $2.89B | $3.30B | $3.67B | $4.28B | $4.77B |
| High | $2.93B | $3.34B | $3.67B | $4.34B | $4.83B |
| EBITDA Avg | $-499M | $-570M | $-629M | $-740M | $-824M |
| Low | $-502M | $-574M | $-629M | $-744M | $-829M |
| High | $-495M | $-566M | $-629M | $-734M | $-818M |
| EBIT Avg | $-503M | $-574M | $-633M | $-745M | $-830M |
| Low | $-506M | $-578M | $-633M | $-749M | $-835M |
| High | $-499M | $-570M | $-633M | $-739M | $-823M |
| Net Income Avg | $20M | $26M | $65M | $109M | $145M |
| Low | $20M | $26M | $40M | $108M | $143M |
| High | $20M | $26M | $90M | $109M | $146M |
| EPS Avg | $0.04 | $0.05 | $0.13 | $0.21 | $0.28 |
| Low | $0.04 | $0.05 | $0.08 | $0.21 | $0.28 |
| High | $0.04 | $0.05 | $0.17 | $0.21 | $0.28 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 2 / 2 | 1 / 1 | 1 / 1 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $728M | $723M | $710M | $857M | $828M | $824M | $807M | $926M |
| Low | $726M | $721M | $708M | $854M | $825M | $822M | $804M | $923M |
| High | $730M | $725M | $712M | $859M | $830M | $827M | $809M | $929M |
| EBITDA Avg | $-125M | $-124M | $-122M | $-147M | $-142M | $-141M | $-138M | $-159M |
| Low | $-125M | $-124M | $-122M | $-147M | $-142M | $-142M | $-139M | $-159M |
| High | $-125M | $-124M | $-121M | $-147M | $-142M | $-141M | $-138M | $-158M |
| EBIT Avg | $-126M | $-125M | $-123M | $-148M | $-143M | $-142M | $-139M | $-160M |
| Low | $-126M | $-125M | $-123M | $-148M | $-143M | $-143M | $-140M | $-160M |
| High | $-125M | $-124M | $-122M | $-148M | $-143M | $-142M | $-139M | $-159M |
| Net Income Avg | $21M | $-3M | $-28M | $37M | $36M | $-740,177 | $-34M | $46M |
| Low | $20M | $-3M | $-28M | $37M | $36M | $-742,850 | $-35M | $46M |
| High | $21M | $-3M | $-27M | $37M | $36M | $-737,168 | $-34M | $46M |
| EPS Avg | $0.04 | $-0.00 | $-0.05 | $0.07 | $0.07 | $-0.00 | $-0.06 | $0.09 |
| Low | $0.04 | $-0.00 | $-0.05 | $0.07 | $0.07 | $-0.00 | $-0.06 | $0.09 |
| High | $0.04 | $-0.00 | $-0.05 | $0.07 | $0.07 | $-0.00 | $-0.06 | $0.09 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |